Clinical Trials Logo
  1. Home
  2. Other
  3. NCT05141422

A Drug-drug Interaction Study of SHR2150 on Healthy Chinese Volunteers

Human Immunodeficiency Virus Infection Clinical Trial

Official title:
A Single-centre, Single-arm, Open-label and Fixed-sequence Drug-drug Interaction Study to Evaluate the Effect of Efavirenz on the Pharmacokinetics of SHR2150 in Healthy Chinese Subjects

Clinical Trial Summary

The study is a single-centre, open-label, fixed-sequence, self-controlled clinical trial. It is planned to enroll 20 healthy adult subjects. Subjects will take SHR2150 on Day 1 and Day 21, and take efavirenz from Day 7 to Day 26.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

  • Acquired Immunodeficiency Syndrome
  • HIV Infections
  • Human Immunodeficiency Virus Infection
Clinical Trial Details
NCT number NCT05141422
Study type Interventional
Source Jiangsu HengRui Medicine Co., Ltd.
Contact
Status Active, not recruiting
Phase Phase 1
Start date December 13, 2021
Completion date January 22, 2022
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05981807 - HPV Infection, Sexually Transmitted Infections and Anal Dysplasia in the Transgender Population
Completed NCT01490359 - Men Together Making a Difference: Reducing HIV/STD Risk Behavior Among South African Men N/A
Completed NCT03143205 - Gene Expression Outcomes in Interventions for Substance Using HIV+ Minority Men N/A
Completed NCT02738138 - A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2) Phase 3
Completed NCT01791465 - Pilot Study of Bydureon to Treat Diabetes in HIV-infected Adults Phase 4
Completed NCT01869634 - Mechanisms of Immune Reconstitution & Reduced Immune Activation Following Darunavir-based ART Phase 4
Completed NCT01662336 - Real-life Effectiveness of the Kaletra Adherence Support Assistance (KASA) Program N/A
Completed NCT01383005 - Treatment Perception of QD (Once a Day) Dosed Kaletra (Tablets) N/A
Completed NCT01328158 - Drug Use Investigation of Kaletra Tablets (Once Daily Administration) on Patients With HIV-infection N/A
Completed NCT00711009 - Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL) Phase 3
Completed NCT02817451 - DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected Infants Phase 3
Completed NCT02214173 - The Effect of an Enhanced Rice Bran Nutritional Supplement in HIV N/A
Completed NCT03284645 - Viral and Antiretroviral Dynamics in HIV-1 Mother-to-Child Transmission Fluids
Terminated NCT01737359 - A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects. Phase 2
Completed NCT01939197 - A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 Coinfection Phase 2/Phase 3
Completed NCT01447680 - Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody Testing N/A
Not yet recruiting NCT05769413 - Awareness of Osteoporosis in HIV Patients
Withdrawn NCT01738555 - A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects Phase 2